Synthesis and pharmacological effects of some alkyl-, aryl-, and aralkylsydnonimines.
D000818:Animals; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D003641:Deamination; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism; D007928:Lethal Dose 50; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors; D010069:Oxadiazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D013566:Sympathomimetics / Q000494:pharmacology; D014439:Tyramine / Q000378:metabolism
D008996:Monoamine Oxidase Inhibitors; D010069:Oxadiazoles; D013566:Sympathomimetics; D012701:Serotonin; D004298:Dopamine; D014439:Tyramine